COMP Career Catalyst: “Leaders in Professional Collaboration” - April 13th, 2026!

The fourth COMP Career Catalyst session of the 2025/2026 year is open for registration! Join for an insightful seminar on 'Leaders in Professional Collaboration': 

Date: Monday, April 13th, 2026 Time: 10:30 AM - 12:00 PM PT / 1:30 PM - 3:00 PM ET Location: Virtual (Zoom) Register Here: https://tinyurl.com/yc3y2u7d  

This 1.5 virtual session will feature an open discussion on the importance of collaboration in establishing remote satellite radiotherapy sites (such as the Corner Brook site developed in partnership with NL Health Services), in enabling intraprovincial coordination during crises (e.g., hospital cyberattacks, flooding, or other disruptions), and in fostering industry partnerships that support innovation and companies like Medscint.

• Maria (Ria) Corsten, MSc, MCCPM, CHE is the Provincial Manager of Medical Physics and the Program Radiation Safety Officer for the Provincial Cancer Care Program in Newfoundland and Labrador with over 25 years of experience in the field.  She earned her Master’s in Medical Physics at Carleton University. She is currently the Treasurer of COMP and a member of the Canadian Partnership for Quality Radiotherapy (CPQR) steering committee. Her interests include quality, safety, and clinical efficiency. She has developed a satellite radiation therapy site at Corner Brook to help  patients access treatment closer to home. 
• Dr. Jean-Pierre Bissonnette is the Associate Head for Professional and Academic Affairs for the Department of Medical Physics at the Princess Margaret Cancer Centre, where he has been employed since 2003. Prior, he was the coordinator then interim Head of Physics at the Centre Hospitalier de l’Université de Montréal. He graduated from McGill University with a M.Sc., then obtained his Ph.D. from the University of Western Ontario in 1996. Dr. Bissonnette has been active in quality assurance and patient safety, high-precision radiotherapy for the brain and the lung, post-graduate education, and monitoring response of locally-advanced lung cancer to combined chemo-radiotherapy using CT, CBCT and PET images. Current research topics include dose reconstruction based on image-guidance images, image-based adaptation of therapy, and exploring the use of statistical tools to rationalize and limit the cost of quality control work.
• Dr. François Therriault-Proulx is the co-founder and CEO of Medscint, where he leads the development of advanced scintillation dosimetry solutions for radiation oncology. A physicist and entrepreneur with a PhD from Université Laval and postdoctoral training at MD Anderson Cancer Center, he has authored over 25 scientific publications and holds multiple patents in optical dosimetry. Medscint is a Canadian medical technology company that specializes in innovative plastic scintillation dosimetry solutions for advanced radiotherapy quality assurance. Founded in 2018 and headquartered in Québec City, the company develops real-time dose measurement systems—such as its flagship HYPERSCINT QA platform—that provides high-precision optical scintillation dosimetry. Their patented technology is specifically designed to address complex challenges in modern oncology, including small-field dosimetry, adaptive radiotherapy, and ultra-high dose-rate (FLASH) applications.

Important: 

To ensure the security of our Zoom sessions, all participants are required to register using an institutional email address. Registrations made with non-institutional emails will be removed from the session. If you do not have an institutional email but would like to attend, please contact Fletcher (fletcher.barrett@ucalgary.ca) and Alaina (alainagiang.bui@mail.utoronto.ca)

See you there!

COMP Student Council